Captor Therapeutics Spolka Akcyjna
CTX.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 197,098 | PLN 464,571 | PLN 666,901 | PLN 742,209 |
| - Cash | PLN 39,257 | PLN 75,704 | PLN 71,036 | PLN 117,943 |
| + Debt | PLN 5,637 | PLN 3,778 | PLN 6,952 | PLN 8,181 |
| Enterprise Value | PLN 163,478 | PLN 392,645 | PLN 602,817 | PLN 632,447 |
| Revenue | PLN 15,825 | PLN 13,201 | PLN 9,158 | PLN 3,986 |
| % Growth | 19.9% | 44.1% | 129.8% | – |
| Gross Profit | PLN 6,423 | PLN 6,901 | PLN 7,071 | PLN 3,245 |
| % Margin | 40.6% | 52.3% | 77.2% | 81.4% |
| EBITDA | -PLN 32,930 | -PLN 64,764 | -PLN 28,221 | -PLN 24,410 |
| % Margin | -208.1% | -490.6% | -308.2% | -612.4% |
| Net Income | -PLN 38,426 | -PLN 70,584 | -PLN 35,894 | -PLN 32,572 |
| % Margin | -242.8% | -534.7% | -391.9% | -817.2% |
| EPS Diluted | -8.25 | -15.19 | -8.61 | -7.89 |
| % Growth | 45.7% | -76.4% | -9.1% | – |
| Operating Cash Flow | -PLN 31,638 | -PLN 52,204 | -PLN 22,948 | -PLN 28,473 |
| Capital Expenditures | -PLN 424 | -PLN 3,005 | -PLN 892 | -PLN 5,113 |
| Free Cash Flow | -PLN 32,062 | -PLN 55,209 | -PLN 23,840 | -PLN 33,586 |